Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
<p style="text-align:justify;"> <b>Background:</b> Postinfectious cough is common in primary care, but has no proven effective treatments. Cysteinyl leukotrienes are involved in the pathogenesis of postinfectious cough and whooping cough (pertussis). We investigated the...
Main Authors: | Wang, K, Birring, S, Taylor, K, Fry, N, Hay, A, Moore, M, Jin, J, Perera, R, Farmer, A, Little, P, Harrison, T, Mant, D, Harnden, A |
---|---|
Format: | Journal article |
Published: |
Elsevier
2013
|
Similar Items
-
Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial.
by: Wang, K, et al.
Published: (2014) -
Montelukast for postinfectious cough in adults: A double-blind randomised placebo-controlled trial
by: Wang, K, et al.
Published: (2014) -
Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
by: Wang, K, et al.
Published: (2014) -
Theobromine for the treatment of persistent cough: a randomised, multicentre, double-blind, placebo-controlled clinical trial
by: Morice, A, et al.
Published: (2017) -
Early use of antibiotics for at risk children with influenza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial
by: Wang, K, et al.
Published: (2018)